(Reposted From CancerDaily)
Study of patients with epithelial adenocarcinoma of ovarian, tubal or
peritoneal origin who had a complete clinical response to their primary
treatment (surgery and chemotherapy). This study is being conducted in:
- London, Ontario
http://www.centerwatch.com/studies/LISTING.HTM
Gene Therapy Study in patients with Metastatic Melanoma. This study is
being conducted in:
- Boston, MA
http://www.centerwatch.com/studies/LISTING.HTM
Gene Therapy Study in patients with Stage III or IV Melanoma with No
Treatment Alternatives. This study is being conducted in:
- Boston, MA
http://www.centerwatch.com/studies/LISTING.HTM
----
Robert W. Neill, Jr.,
CancerDaily
http://rwneill.com
To subscribe to CancerDaily, send a blank
email to cancerdaily-subscribe@egroups.com
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
